Yuval Cohen
Chief Executive Officer at Corbus Pharmaceuticals Holdings Inc.
Sits on 1 board. Last updated September 28, 2026
Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 4 years
- Director since
- 2023
4 years of board service in total across 1 board, counting each seat separately. Longest: Corbus Pharmaceuticals Holdings Inc., 3 years.
Chief executive roles
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Corbus Pharmaceuticals Holdings Inc. May 13, 202699.1%
-
Corbus Pharmaceuticals Holdings Inc. May 15, 202599.0%
-
Corbus Pharmaceuticals Holdings Inc. May 16, 202499.7%
-
Corbus Pharmaceuticals Holdings Inc. May 18, 202387.1%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Aug 7, 2026 | Corbus Pharmaceuticals Holdings Inc. | Open-market sale | −17,000 | $10.08 | $171,360 |
| Feb 13, 2026 | Corbus Pharmaceuticals Holdings Inc. | Open-market sale | −13,871 | $7.78 | $107,916 |
| Jan 14, 2026 | Corbus Pharmaceuticals Holdings Inc. | Grant or award | +50,000 | — | — |
| Oct 27, 2025 | Corbus Pharmaceuticals Holdings Inc. | Option exercise | +8,973 | $4.26 | $38,225 |
| Oct 27, 2025 | Corbus Pharmaceuticals Holdings Inc. | Open-market sale | −8,973 | $17.14 | $153,797 |
| Oct 24, 2025 | Corbus Pharmaceuticals Holdings Inc. | Option exercise | +18,660 | $4.26 | $79,492 |
| Oct 24, 2025 | Corbus Pharmaceuticals Holdings Inc. | Open-market sale | −18,660 | $17.01 | $317,407 |
| Feb 14, 2025 | Corbus Pharmaceuticals Holdings Inc. | Open-market sale | −7,134 | $8.76 | $62,494 |
| Jan 31, 2025 | Corbus Pharmaceuticals Holdings Inc. | Grant or award | +68,100 | — | — |
| Jun 18, 2024 | Corbus Pharmaceuticals Holdings Inc. | Option exercise | +11,667 | $30.00 | $350,010 |
| Jun 18, 2024 | Corbus Pharmaceuticals Holdings Inc. | Open-market sale | −11,667 | $42.24 | $492,814 |
| Jun 18, 2024 | Corbus Pharmaceuticals Holdings Inc. | Option exercise | +1,770 | $14.10 | $24,957 |
| Jun 18, 2024 | Corbus Pharmaceuticals Holdings Inc. | Open-market sale | −1,770 | $42.24 | $74,765 |
| Jun 18, 2024 | Corbus Pharmaceuticals Holdings Inc. | Option exercise | +2,322 | $4.26 | $9,892 |
| Jun 18, 2024 | Corbus Pharmaceuticals Holdings Inc. | Open-market sale | −2,322 | $42.24 | $98,081 |
Questions about Yuval Cohen
What boards is Yuval Cohen on?
Yuval Cohen sits on the board of Corbus Pharmaceuticals Holdings Inc.
What company is Yuval Cohen the CEO of?
Yuval Cohen is Chief Executive Officer of Corbus Pharmaceuticals Holdings Inc.
How long has Yuval Cohen served on boards?
Our records show at least 4 years of board service across 1 board, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.